|
|
|
|
|
|
by loeg
478 days ago
|
|
|
FDA has determined the shortages of the non-compounded versions has been resolved (of zepbound/tizepatide in October 2024, and wegovy/semaglutide last week): https://www.fda.gov/drugs/drug-safety-and-availability/fda-c... So compounders can no longer legally sell tirzepatide and will soon (April-May) be unable to legally sell semaglutide. |
|
|